Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-22-059528
Filing Date
2022-05-12
Accepted
2022-05-12 17:00:46
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tm2215148d1_424b5.htm 424B5 8936
2 GRAPHIC tm2215148d1_424b5img001.jpg GRAPHIC 18851
3 GRAPHIC tm2215148d1_424b5img002.jpg GRAPHIC 3239
  Complete submission text file 0001104659-22-059528.txt   40956
Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-255841 | Film No.: 22918790
SIC: 2834 Pharmaceutical Preparations